Pat Cotroneo
2019
In 2019, Pat Cotroneo earned a total compensation of $4.3M as Chief Financial Officer at FibroGen, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $264,600 |
|---|---|
| Option Awards | $1,769,851 |
| Salary | $490,000 |
| Stock Awards | $1,782,963 |
| Other | $18,972 |
| Total | $4,326,386 |
Cotroneo received $1.8M in stock awards, accounting for 41% of the total pay in 2019.
Cotroneo also received $264.6K in non-equity incentive plan, $1.8M in option awards, $490K in salary and $19K in other compensation.
Rankings
In 2019, Pat Cotroneo's compensation ranked 2,685th out of 13,971 executives tracked by ExecPay. In other words, Cotroneo earned more than 80.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,685 out of 13,971 | 81st |
Division Manufacturing | 967 out of 5,695 | 83rd |
Major group Chemicals And Allied Products | 316 out of 2,194 | 86th |
Industry group Drugs | 257 out of 1,880 | 86th |
Industry Pharmaceutical Preparations | 190 out of 1,392 | 86th |
Source: SEC filing on April 23, 2020.
Cotroneo's colleagues
We found five more compensation records of executives who worked with Pat Cotroneo at FibroGen in 2019.
2019
Thomas Neff
FibroGen
Chief Executive Officer
2019
K Yu
FibroGen
Chief Medical Officer
2019
James Schoeneck
FibroGen
Chief Executive Officer
2019
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
2019
Christine Chung
FibroGen